(Q46881201)

English

Valganciclovir prevents cytomegalovirus reactivation in patients receiving alemtuzumab-based therapy

scientific article published on 26 November 2007

Statements

Valganciclovir prevents cytomegalovirus reactivation in patients receiving alemtuzumab-based therapy (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit